These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32675402)

  • 1. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
    Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
    Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
    Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
    J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas.
    Gregory J; Paisant A; Paulatto L; Raynaud L; Bertin C; Kerbaol A; Vullierme MP; Paradis V; Vilgrain V; Ronot M
    Eur J Radiol; 2020 Jul; 128():109027. PubMed ID: 32361381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
    Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
    AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound features of hepatocellular adenoma and the additional value of contrast-enhanced ultrasound.
    Dong Y; Zhu Z; Wang WP; Mao F; Ji ZB
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):48-54. PubMed ID: 26818543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
    AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.
    Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H
    Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New MRI features improve subtype classification of hepatocellular adenoma.
    Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
    Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
    AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
    Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
    Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of color parametric imaging and contrast-enhanced ultrasound in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma.
    Liu YH; Fan ZH; Yin SS; Yan K; Sun LQ; Jiang BB
    J Clin Ultrasound; 2022 Feb; 50(2):216-221. PubMed ID: 35084048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
    Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
    Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
    Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
    Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
    Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence.
    Roche V; Pigneur F; Tselikas L; Roux M; Baranes L; Djabbari M; Costentin C; Calderaro J; Laurent A; Rahmouni A; Luciani A
    Eur Radiol; 2015 Jan; 25(1):186-95. PubMed ID: 25120205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
    Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
    Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound.
    Taimr P; Bröker MEE; Dwarkasing RS; Hansen BE; de Knegt RJ; De Man RA; IJzermans JNM
    Ultrasound Med Biol; 2017 Oct; 43(10):2144-2150. PubMed ID: 28743375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.
    Tse JR; Naini BV; Lu DS; Raman SS
    Radiology; 2016 Apr; 279(1):118-27. PubMed ID: 26505921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.